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P113 is a merozoite surface protein that binds
the N terminus of Plasmodium falciparum RH5
Francis Galaway1, Laura G. Drought2, Maria Fala1, Nadia Cross2, Alison C. Kemp2, Julian C. Rayner2
& Gavin J. Wright1,2
Invasion of erythrocytes by Plasmodium falciparum merozoites is necessary for malaria
pathogenesis and is therefore a primary target for vaccine development. RH5 is a leading
subunit vaccine candidate because anti-RH5 antibodies inhibit parasite growth and the
interaction with its erythrocyte receptor basigin is essential for invasion. RH5 is secreted,
complexes with other parasite proteins including CyRPA and RIPR, and contains a conserved
N-terminal region (RH5Nt) of unknown function that is cleaved from the native protein. Here,
we identify P113 as a merozoite surface protein that directly interacts with RH5Nt. Using
recombinant proteins and a sensitive protein interaction assay, we establish the binding
interdependencies of all the other known RH5 complex components and conclude that the
RH5Nt-P113 interaction provides a releasable mechanism for anchoring RH5 to the merozoite
surface. We exploit these findings to design a chemically synthesized peptide corresponding
to RH5Nt, which could contribute to a cost-effective malaria vaccine.
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M
alaria is a deadly infectious disease caused by
Plasmodium parasites which is responsible for up to
one million deaths annually, primarily in young
children living in sub-Saharan Africa1. Malaria symptoms result
from the blood stages of P. falciparum infections when a form of
the parasite called the merozoite recognizes and invades host
erythrocytes where it replicates asexually2. Since invasion is an
essential and extracellular step in the parasite lifecycle, it may be
targeted by vaccine-induced antibodies3. After initial recognition
of the host erythrocyte, the pear-shaped merozoite orientates
itself so that its apical protuberance is in direct apposition to the
host membrane. This triggers the subsequent release of parasite
invasion ligands from intracellular secretory organelles including
the micronemes and rhoptries3,4. An electron-dense nexus
between the host and parasite membranes is formed which
opens out into a ring-like moving junction which envelops the
merozoite, finally resealing behind it, such that the parasite is
completely internalized within an intraerythrocytic parasito-
phorous vacuole5. The whole process is rapid, taking just a
few seconds6. The biochemical interactions involved in invasion
are being identified, and their roles in each of these steps
determined4. Of particular current interest is the interaction
between the parasite reticulocyte-binding protein homologue 5
(RH5) and its erythrocyte receptor, basigin7.
RH5 was first identified by searching the P. falciparum genome
sequence for homology with the sequences of other RH family
members, and the inability to select RH5-deficient parasites
in vitro suggested it was required for blood-stage growth8. The
role of RH5 as an invasion ligand was established by the
identification of basigin as its erythrocyte receptor, and
the demonstration that the RH5-basigin interaction was both
essential and universally required for invasion9. RH5 is detected
within the rhoptries of merozoites, relocating to the moving
junction during invasion8. Live imaging in the presence of
fluorescent calcium-sensitive dyes and RH5-basigin interaction
antagonists revealed that merozoites could still adhere and
deform erythrocytes leading to the conclusion that the RH5-
basigin interaction was necessary for, and directly preceded,
rhoptry release just before the formation of the moving junction4.
The protein sequence of RH5 is conserved between strains10, can
elicit antibodies that inhibit parasite growth in vitro11–14, and
RH5-based vaccines are protective in a non-human primate
P. falciparum infection model15. These properties of RH5 have
made a deeper understanding of its mechanism of action a
priority but many basic questions remain unanswered. For
example, the lack of any obvious protein sequence feature for
anchoring RH5 to a membrane suggests the existence of another
mechanism for tethering RH5 to the merozoite surface. In
addition, RH5 is detected in parasite culture supernatants as both
full length (RH5FL,  63kDa) and processed (RH5Ct,  45 kDa)
forms but the function of this processing is unknown8.
Peptide sequencing of purified recombinant RH5 and anti-RH5
antibodies with known epitope locations revealed that RH5Ct
lacks the N-terminal region (RH5Nt), which is predicted to
be disordered8,16–18. RH5Ct folds into a ‘kite’-like shape19,20 and
contains a small (B1,500Å2) binding interface for basigin,
consistent with the low interaction affinity (KD B1 mM)9, leaving
much of its solvent-exposed surface available for simultaneous
binding with other proteins. Size separation of parasite proteins
from culture supernatants by gel filtration revealed that RH5 is
part of a larger (B200 kDa) complex, that includes two other
parasite proteins: RIPR (RH5 interacting protein)16 and CyRPA
(cysteine-rich protective antigen)21. Both RIPR and CyRPA are
predicted to be secreted proteins16,22 (although see ref. 21) which
suggests that they do not tether RH5 to the merozoite surface.
Because these proteins were identified from bulk parasite extracts
as purified complexes, we do not know whether RIPR and CyRPA
bind RH5 directly, nor whether they interact in a mutually
exclusive fashion. One further intriguing and unanswered
question in relation to the function of RH5 is the role of its N
terminus (RH5Nt), which is absent from the processed form of
RH5 detected in parasite culture supernatants. This region is
predicted to be highly disordered and flexible, to such a degree
that it was purposefully removed to promote crystal formation for
structural studies19,20. Despite this, RH5Nt is particularly well
conserved with just a single non-synonymous polymorphism
described at very low frequency (o1%) in African isolates13, and
contains the epitope for a potent invasion-blocking monoclonal
antibody18 demonstrating RH5Nt has an important role in RH5
function.
Here we use a sensitive assay that detects interactions between
recombinant proteins to show that the glycosylphosphatidylino-
sitol (GPI)-linked protein P113 interacts directly with the
N terminus of unprocessed RH5, providing a mechanism by
which the RH5 invasion complex is tethered to the merozoite
surface. We additionally determine the binding interdependencies
between the individual components of the RH5-basigin invasion
complex, which, together with RH5 processing, suggests the
existence of a one-way switching mechanism that releases the
RH5 complex from the merozoite surface during erythrocyte
invasion by P. falciparum.
Results
The N terminus of RH5 has no role in basigin binding. The
Plasmodium falciparum RH5 protein is detected as full length and
processed forms in both parasite culture supernatants and when
expressed recombinantly in either mammalian13 or insect cells20.
To identify the sites of processing when expressed in mammalian
cells, RH5 was purified, resolved as four bands by SDS–PAGE,
and the N terminus of each determined by Edman protein
sequencing. The major band (RH5Ct) was consistent with the
main processed form of RH5 observed in parasite supernatants
(Fig. 1a) and its N terminus is close (14 amino acids C-terminal)
to the cleavage site observed when RH5 is expressed in insect
cells20. The largest band matched the expected mass of the
full-length unprocessed protein (RH5FL) and this was confirmed
by protein sequencing (Fig. 1a). To determine which of the
processed forms were able to interact with the basigin receptor,
we made recombinant forms of RH5 corresponding to each of
these fragments and tested their ability to bind basigin using a
protein interaction assay designed to detect low-affinity
extracellular protein interactions called AVEXIS (for AVidity-
based EXtracellular protein Interaction Screen23) (Fig. 1b).
Consistent with the co-crystal structure of RH5 with its
receptor, we observed that RH5Ct bound basigin, whereas
RH5Nt did not (Fig. 1b). We used surface plasmon resonance
(SPR) to show that RH5Ct bound with similar binding
parameters to the full-length RH5 protein9 (Supplementary
Table 1; Fig. 1c). Altogether, these data demonstrate that the
N-terminal region of RH5 does not play a direct role in basigin
binding.
P113 interacts with the N terminus of RH5. We reasoned that
the cleaved N-terminal region of RH5 might form a distinct
binding domain, and because antibodies to this region have
shown potent parasite inhibitory activity18, could be important
for RH5 function. One possible role would be to tether RH5
to the surface of the merozoite by interacting with another
membrane-anchored parasite protein. We therefore used RH5Nt
expressed as a highly avid, pentamerized, enzyme-tagged ‘prey’
and the AVEXIS assay to systematically screen an existing library
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of full-length recombinant P. falciparum merozoite ‘bait’
proteins24,25. In total, we screened 39 different parasite proteins
which included the known parasite RH5-interacting partners
RIPR and CyRPA. We reproducibly identified an interaction with
a merozoite protein called P113; no interactions with either RIPR
or CyRPA were detected (Fig. 2a). P113 was initially discovered in
a study designed to identify GPI-anchored merozoite proteins by
purifying detergent-resistant membrane proteins from mature
blood-stage parasites26, and was subsequently found to be one of
the most abundant proteins isolated from high molecular mass
complexes on the merozoite27. P113 has been detected at
other stages of the lifecycle including the sporozoite28 and
gametocyte29, and the inability to select P113-deficient parasites
suggests that it is essential for blood-stage growth2. An
informative and rapid validation test for interactions detected
using the AVEXIS approach is to determine whether the
interaction is dependent on the bait-prey orientation23. To
establish this, we expressed the entire ectodomain of P113 as an
avid prey, and showed that it could interact with both RH5Nt and
RH5FL, but not RH5Ct (Fig. 2b). We further demonstrated this
interaction by showing that RH5Nt but not control RH5Ct-
coated beads could purify native P113 from parasite culture
lysates (Fig. 2c). Using antibodies against P113, we could show
that it is expressed in early and late-stage schizonts and on the
surface of free merozoites by co-staining with the established
merozoite surface markers MSP9 (Fig. 2d) and MSP1 (Supple-
mentary Fig.1a), findings that are consistent with an independent
study30. Antibodies to P113, unlike those to a marker of the inner
membrane complex (MTIP), stained both permeabilized and
unpermeabilized merozoites demonstrating P113 is surface
localized (Supplementary Fig.1b). These data identify P113 as
an RH5 interacting partner at the merozoite surface and a new
member of the RH5 complex.
Mapping the P113-RH5 interaction interface. We next asked
which region within RH5Nt contained the P113 binding site.
Using a series of truncated RH5Nt recombinant proteins and the
AVEXIS assay, we determined a minimal P113 binding region
corresponding to a linear sequence of 19 amino acids that bound
P113 indistinguishably from RH5Nt (Fig. 3a). To similarly
demonstrate where on P113 the RH5 binding site was located, a
series of truncated P113 expression constructs, based on
both predicted subtilisin cleavage sites31 and the location of
structurally important cysteine pairings were tested for RH5FL
binding (Fig. 3b). The smallest region of P113 that could be
expressed, and which retained the ability to bind RH5
encompassed a cluster of 14 cysteine residues at the N terminus
of P113 (Fig. 3b). These data identify that the P113 interaction
site on RH5 is encompassed within a short linear sequence of just
19 amino acids.
P113 binds RH5Nt and with higher affinity to RH5FL. To
confirm that RH5 and P113 interact directly and to quantify the
biophysical parameters of the interaction, we used SPR. RH5Nt
was expressed as a soluble recombinant protein, purified, and
serial dilutions injected over P113 immobilized on a sensor chip.
Saturable binding was observed demonstrating the specificity of
the interaction from which an equilibrium binding constant (KD)
of 3.0±0.5 mM (mean±s.d., n¼ 2) was derived (Fig. 4a). Inde-
pendent kinetic parameters were in agreement with the equili-
brium data (Fig. 4b), and although weak, they were within the
expected range of many extracellular interactions measured using
this technique32. Interestingly, the affinity of the interaction was
10-fold higher (KDB0.3 mM) when full-length RH5 protein was
used as the analyte by comparison to the N-terminal region alone
(Fig. 4c). To investigate this in more detail, and remove possible
measurement inaccuracies due to the use of different analytes, we
measured the biophysical binding parameters in the reverse
orientation by using purified P113 as the analyte. We observed
that the purified P113 entire ectodomain resolved with a broad
profile by size-exclusion chromatography (SEC) with the peak
eluting earlier than expected for a monomeric protein suggesting
that the ectodomain of P113 self-associated (Fig. 4d). Resolving
the fractions corresponding to the elution peak by denaturing
and non-denaturing PAGE revealed apparent masses of B130
and B500 kDa respectively, consistent with the formation of
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Figure 1 | The N-terminal domain of RH5 is not involved in basigin binding. (a) Purified tagged recombinant RH5 expressed by HEK293 cells resolved as
four species by SDS–PAGE under reducing conditions. The N-terminal sequence of each species was determined by Edman degradation and is shown.
(b) The N-terminal region of RH5 is not involved in basigin binding. The indicated RH5 fragments were expressed as biotinylated bait proteins and probed
for interactions with a highly avid b-lactamase-tagged basigin prey protein using the AVEXIS assay. The full length (FL) and the major processed form
(RH5Ct) of RH5 bound basigin but the N-terminal region (RH5Nt) did not. Bars represent means±95% confidence intervals; n¼ 3. (c) Biophysical analysis
of the RH5Ct-basigin interaction. Serial dilutions of the indicated concentrations of purified RH5Ct protein were injected over the biotinylated ectodomain
of basigin immobilized on a streptavidin-coated sensor chip. The data showed excellent fits to a simple (1:1) binding model (red line). The binding
parameters of RH5Ct did not differ significantly from those obtained from RH5FL (Supplementary Table 1) demonstrating that the N-terminal region of RH5
does not contribute to basigin binding affinity.
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tetrameric complexes (Fig. 4e). Analysis of the P113 protein
sequence identified a probable coiled-coil region at the C
terminus of the protein33 and similar sequence features have
been implicated in the tetramerization of other merozoite
proteins such as MSP334. As expected, when the oligomeric
P113 complexes were used as analytes in SPR experiments,
the shape of the binding curves indicated complex multi-
valent binding to RH5 immobilized on the sensor chip, which
dissociated slowly (Fig. 4f). In an attempt to measure monomeric
binding of P113 to RH5Nt for direct comparisons of biophysical
binding parameters, we observed that one of the highly-expressed
P113 fragments that lacked the predicted coiled-coil region at the
C terminus (Y1-N653, Fig. 3b) eluted in much later fractions by
SEC (Fig. 4d,e), and when used as the analyte, this truncated form
of P113 bound to RH5FL with monophasic binding
characteristics and the same ten-fold higher interaction affinity
compared to RH5Nt (Fig. 4g, Supplementary Table 1). A kinetic
analysis of the interaction confirmed that the higher binding
affinity of RH5FL compared to RH5Nt is mainly due to a
slower (approximately fourfold) dissociation rate constant, but a
higher (approximately twofold) association rate constant also
contributes (Supplementary Table 1). We also performed a
thermodynamics analysis of the RH5-P113 interaction using SPR
which showed that the interaction was entropically driven and
that the entropic contribution was higher for RH5FL compared to
RH5Nt providing an explanation for the 10-fold higher affinity of
RH5FL for P113 in comparison to RH5Nt (Supplementary
Fig. 2). This suggests that the N terminus of RH5 may be partially
ordered or in some way structurally constrained when in
proximity to the C terminus of RH5, and that the interaction
with P113 would release RH5Nt from this restraint thereby
causing an overall increase in disorder and consequently a
more favourable entropic contribution upon P113 binding. To
put these values into context, RH5FL binds P113 with an
approximately three-fold higher binding affinity than it binds to
the basigin receptor9, and approximately three-fold lower once
processed. Together, these data suggest P113 clusters, probably as
tetramers, at the merozoite surface via a membrane-proximal
coiled coil region, and binds the N terminus of RH5 with an
affinity that is reduced around 10-fold after processing.
RH5 directly interacts with P113 and CyRPA but not RIPR.
The identification of P113 adds another component to the RH5
invasion complex that is known to include the merozoite proteins
CyRPA21 and RIPR16, which both co-immunoprecipitate with
RH5 from parasite supernatants. Identifying protein complexes
using this method does not immediately establish which proteins
directly interact with each other, nor whether the components
can bind simultaneously. To address these questions, we used our
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Figure 2 | The N-terminal domain of RH5 interacts with the merozoite surface protein P113. (a) The N-terminal domain of RH5 (RH5Nt, F1-K116) was
expressed as a pentameric, b-lactamase-tagged prey protein and systematically tested for interactions against a library of recombinant P. falciparum
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collection of recombinant P. falciparum merozoite proteins
expressed in mammalian cells24,25 together with the AVEXIS
assay. Previously, we have shown that direct binary interactions
can be detected using this approach between RH5FL/Ct and
basigin (Fig. 1b and9) as well as RH5FL/Nt and P113 (Fig. 2b).
Screening the merozoite protein library with an RH5FL
pentameric ‘prey’ identified the expected interactions with both
P113 and CyRPA baits demonstrating direct binding of RH5 with
each of these proteins (Supplementary Fig. 3a). We additionally
determined that the CyRPA binding site on RH5 was located in
the RH5Ct fragment since RH5Ct but not RH5Nt bound CyRPA
(Supplementary Fig. 3b). The same interactions were detected
when the bait-prey orientations were reversed with RH5FL
presented as a monomeric ‘bait’—an important validation criteria
used for AVEXIS assays (Supplementary Fig. 3c). We did not
observe any other interactions with RH5FL, including RIPR
(Supplementary Fig. 3a,c). CyRPA, however, did directly interact
with RIPR (Supplementary Fig. 3b) suggesting that CyRPA
bridges the interaction between RH5 and RIPR. No direct
interactions were detected between P113 and either CyRPA or
RIPR (Supplementary Fig. 3d). Altogether, these data establish
that P113 and CyRPA bind directly to RH5 while RIPR is
associated with RH5 through a mutual interaction with CyRPA.
RH5-CyRPA-RIPR complex interacts with basigin but not P113.
Given the essential role of the RH5 complex in invasion, we
sought to address the interaction dependencies of each compo-
nent of the RH5 complex with one another. We again took
advantage of our recombinant proteins and AVEXIS assay, but
this time attempted to induce binding between non-interacting
baits and preys by titrating in additional components of the
complex. We first established that a basigin prey could be
captured by a P113 bait by adding increasing concentrations of
purified monomeric RH5FL, but not RH5Ct or RH5Nt (Fig. 5a).
This demonstrated that RH5FL was able to bind both P113 and
basigin simultaneously, consistent with them interacting with
distinct regions of RH5. Similarly, RH5FL (but not RH5Ct or
RH5Nt) could form a trimeric complex involving CyRPA and
P113 (Fig. 5b). RH5FL and RH5Ct—but not RH5Nt—could
interact simultaneously with CyRPA and basigin indicating that
their respective interaction interfaces do not overlap in the
C-terminal region of RH5 (Fig. 5c). Consistent with all these data,
the formation of the basigin-RH5-P113 complex could be
detected in the presence of CyRPA (Fig. 5d). We next showed that
an RH5FL prey could be captured by a RIPR bait only by adding
increasing concentrations of purified CyRPA (Fig. 5e), which
provided an explanation for why RIPR did not directly interact
with RH5 but is co-purified with RH5 from parasite
supernatants16. We next asked whether the complex of the three
parasite proteins RH5, CyRPA and RIPR could interact with
either the erythrocyte or merozoite-tethered receptors. Inter-
estingly, while an interaction could be detected with basigin, we
were unable to detect interactions with P113 (Fig. 5f). Altogether,
these results suggest that RH5-CyRPA-RIPR complexes
containing either RH5FL or RH5Ct can bind the erythrocyte
receptor basigin, but not the merozoite tethering molecule P113.
During the preparation of this manuscript, a report describing
the RH5-CyRPA interaction was published showing that
immunoprecipitated CyRPA was labelled by the addition of
radioactively labelled glucosamine and mannose, suggesting that
CyRPA is post-translationally modified by addition of a GPI
anchor21. To try and confirm this, we took advantage of the fact
that P. falciparum proteins can be appropriately modified with
GPI anchors when expressed in mammalian cells35. By contrast
to P113—which was used as a positive control—we did not find
any evidence that CyRPA was GPI-anchored and surface
localized (Supplementary Fig. 4). Our findings are consistent
with the initial prediction that CyRPA is a secreted protein22 and
the absence of CyRPA-derived peptides from detergent-resistant
P. falciparum schizont membrane fractions that are enriched in
GPI-anchored proteins27. During the late stages of revising this
manuscript for publication, another study has directly shown that
CyRPA is not GPI-anchored36.
An RH5Nt amph-vaccine elicits invasion-blocking antibodies.
Because the RH5 N-terminal region is relatively short and
predicted to be unstructured, we asked whether a chemically
synthesized peptide could elicit invasion-blocking antibodies and
therefore be a component of a cost-effective vaccine. A peptide
corresponding to the first 116 amino acids of RH5 was synthe-
sized with an additional C-terminal cysteine for chemical
coupling. We first showed that the synthetic peptide structurally
mimicked RH5Nt by showing it retained the ability to bind P113
with almost identical biophysical binding parameters to RH5Nt
(Fig. 6a; Supplementary Table 1). Conjugating peptides to
amphiphilic compounds that contain both hydrophobic albumin-
binding acyl lipid chains and a solubilizing hydrophilic PEG
spacer have been shown to improve immune presentation
by promoting lymph node accumulation through ‘albumin
hitchhiking’37. We therefore covalently coupled the peptide
corresponding to RH5Nt to a maleimide-functionalized
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Figure 3 | The P113-RH5 interaction interface involves a short linear
sequence in RH5Nt and the cysteine-rich N-terminal domain of P113.
(a) The P113 interaction interface on RH5 was mapped to 19 amino acids
located within the N terminus of RH5. Fragments of RH5Nt that could be
expressed as prey proteins are depicted schematically and were tested for
their ability to bind a P113 bait protein by AVEXIS. The K9-K27 fragment
represented the minimal binding region. (b) The RH5 interaction interface
on P113 was mapped to the N terminus corresponding to a cysteine-rich
region encompassed by Y1-K197. Fragments of P113, including the entire
ectodomain (EE), that could be expressed as bait proteins are depicted
schematically as in a with the approximate locations of the 16 cysteines
marked by vertical bars. The proteins were tested for their ability to bind an
RH5 prey protein by AVEXIS. Bars represent means±95% confidence
intervals n¼ 3; the experiment shown is one of two independent
experiments.
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PEG2000-DSPE molecule (Fig. 6b) to create an amph-vaccine37.
Polyclonal antibodies against this compound elicited good
antibody titres (Supplementary Fig. 5) that prevented RH5
binding to P113 (Fig. 6c), but not basigin (Fig. 6d). The
antibodies inhibited parasite growth in vitro, an effect that was
observed in both 3D7 and Dd2 parasite strains, and specifically
affected schizont to ring stage progression demonstrating that
they inhibited erythrocyte invasion (Fig. 6e and Supplementary
Fig. 6). These data suggest that a peptide based on the N-terminal
region of RH5 would be an effective and inexpensive component
of a malaria vaccine.
Discussion
RH5 is a strong candidate for inclusion in a malaria vaccine
because it is susceptible to vaccine-elicited antibodies and its
interaction with the basigin receptor is essential for invasion. The
finding that RH5 interacts with both host and parasite proteins
has led to a model whereby RH5 functions as a central organizing
component of a protein complex formed at the nexus of the
merozoite–erythrocyte interface that triggers further rhoptry
release and the formation of an ‘open connection’ through which
other invasion proteins can be delivered to establish the moving
junction4. One missing component of this model is a molecular
explanation for how the secreted RH5 protein is localized to the
merozoite surface. Here we use a library of recombinant proteins
and a sensitive assay designed to detect low-affinity extracellular
interactions to identify the GPI-anchored merozoite surface
protein P113 as a direct interacting partner of RH5 which could
provide such a tethering mechanism. Importantly, we show that
the P113 interaction site on RH5 lies within the N terminus of
RH5—a region which is absent from the major form of RH5
that is detected in parasite culture supernatants, and therefore
provides a regulatory mechanism by which RH5 could be released
from the merozoite surface during invasion. Moreover, by using
individual components of the RH5 complex, we have determined
that not all constituents of the RH5 complex can interact
simultaneously, again suggesting that there is an ordered schedule
of protein interactions that could delineate separable molecular
events during invasion. Adding the contributions described here
into a broader context compiled from many other researchers
suggests the following model (Fig. 7).
Proteomics studies of P. falciparum blood-stage membrane
preparations have shown that P113 is GPI-anchored and one of
the most abundant proteins constitutively present on the
merozoite surface26,27,38, which we show here is likely to be
clustered on the surface as tetramers. There are few studies on
P. falciparum P113, but antibody responses against P113 have
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Figure 4 | The interaction between P113 and the N-terminal region of RH5 is specific and 10-fold stronger in the context of full-length RH5. (a) RH5Nt
bound P113 specifically and with low affinity. Purified monomeric RH5Nt was serially diluted before being injected over 780 RU of monobiotinylated P113
immobilized on a streptavidin-coated sensor chip. The binding traces suggested the presence of a small amount of multimeric material (see Methods);
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used for equilibrium binding. From these data, an equilibrium binding constant (KD) of 3.0±0.5mM (mean±s.d., n¼ 2) was calculated. (b,c) RH5FL binds
P113 with a ten-fold higher affinity than RH5Nt. A kinetic analysis of P113 binding RH5Nt (b) or RH5FL (c) using SPR; inset gels demonstrate the
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(black lines) fitted a simple 1:1 binding model well (red lines), and were used to determine binding constants. (d) Gel filtration elution profiles of the entire
ectodomain (EE) and an N-terminal subfragment (Y1-N653) of recombinant tagged P113 demonstrated that P113 EE can form multimers. The lettered
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approximately fourfold higher mass under native when compared with denaturing conditions. The Y1-N653 fragment resolved as two species by native
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been shown to be associated with protection from malaria in
study cohorts from both Africa39 and Papua New Guinea40.
Although it is unclear precisely when RH5 is proteolytically
cleaved during the rapid invasion process, it is tempting to
speculate that at least a proportion of RH5 is released from
rhoptries as an unprocessed full length form and confined to the
merozoite surface via direct interactions between its N-terminal
region and P113 with a relatively high (KD¼ 0.3 mM) binding
affinity; the clustering of P113 may be important for increasing
local binding avidity for RH5FL. We show here that RH5FL can
simultaneously bind P113 and basigin through the N- and
C-terminal regions, respectively, so that it is molecularly possible
for RH5 to bridge the merozoite and erythrocyte membranes
through these interactions. The P113-RH5-basigin complex may
then trigger secretion of other parasite ligands including the
AMA1/RON complex which lead to the formation of the moving
junction4. We have established here that the secreted CyRPA
protein can bind RH5 within the P113-RH5-basigin complex, and
because we could detect direct interactions between RIPR and
CyRPA but not RH5, CyRPA may perform the role of recruiting
RIPR to the RH5 complex. These findings provide two possible
mechanisms for RH5 complex release from P113 at the merozoite
surface: (1) the proteolytic cleavage of the N-terminal region of
RH5; and (2) the mutually exclusive binding of RIPR and P113 to
the RH5 complex, which suggests that the recruitment of RIPR to
the complex would allow its release from the merozoite surface.
In summary, we suggest that at the moment of invasion, RH5 is
locally concentrated and presented to the basigin receptor at the
site of contact between the merozoite and erythrocyte through
interactions with surface localized P113. The binding of the
CyRPA and RIPR proteins to RH5 may act as a one-way ‘switch’
to licence the next step of the invasion process by releasing the
RH5 complex from the surface-tethered P113 due to the mutually
exclusive binding of RIPR and P113 in the RH5 complex, and/or
recruitment of a protease that cleaves the N-terminal region of
RH5. The identification of the protease/s responsible for RH5
cleavage will be an important step in understanding the function
of the RH5 invasion complex. Whilst the observation that
aprotinin can reduce RH5 processing suggests the involvement of
a serine protease, RH5 is not a predicted or experimentally
validated substrate of the well-characterized parasite blood-stage
serine proteases, the subtilisins including SUB131.
One intriguing evolutionary puzzle is that clearly identifiable
orthologues of each component of the RH5 complex do not
necessarily co-occur in the genomes of different Plasmodium
species: orthologues of both P113 and RIPR are found across
Plasmodium species that infect both primates and rodents;
CyRPA orthologues are present in primate, but not the rodent
parasites; and RH5 is further restricted to a subset of the primate
parasites closely related to P. falciparum within the subgenus
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Figure 5 | The RH5-CyRPA-RIPR complex can interact with basigin but
not P113. The binding interdependencies of the proteins within the RH5
invasion complex with basigin and P113 were determined using modified
AVEXIS assays. The indicated purified monomeric components of the RH5
complex were titrated into binding reactions between the named baits and
b-lactamase-tagged preys, which do not interact directly, and any resulting
prey binding quantified by measuring the hydrolysis of a colorimetric
b-lactamase substrate at 485 nm. Binding data are shown on the left panels
with their interpretations shown schematically on the right. RH5FL can
simultaneously bind P113 and basigin (a), CyRPA and P113 (b), and CyRPA
and basigin (c). (d) The basigin-RH5FL-P113 complex is not overtly affected
by the addition of CyRPA; here, the RH5FL monomer concentration was
titrated with CyRPA held constant at 0.3mM. (e) RH5FL prey could be
captured on a RIPR bait by addition of purified CyRPA. (f) The RH5FL-
CyRPA-RIPR complex interacted with basigin, but not P113 preys; here, the
CyRPA monomer concentration was titrated with RH5FL held constant at
0.2 mM. Binding data points represent means±95% confidence interval
(n¼ 3); a representative experiment from at least two independent
experiments is shown.
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Laverania. Most likely, the proteins encoded by these genes
perform different roles in these species but have been co-opted by
P. falciparum together with the evolution of the RH5 protein for
their roles in invasion. Functional studies in P. berghei, for
example, have shown that P113-deficient parasites could
complete their lifecycle, but had lower numbers of parasites
making the transition from sporozoites to the liver-stage form41;
and, more recently, P113 has been shown to be a peripheral
member of the PTEX translocation machinery which is conserved
across Plasmodium spp.42.
Finally, we show that a linear peptide corresponding to the
N terminus of RH5 retains the functional ability to bind P113
and, importantly, could elicit antibodies that inhibit parasite
growth. This is of interest because peptides can be synthesized
at scale and are chemically defined—both relevant considera-
tions for the production of a vaccine. Recent and continuing
developments in adjuvant-enhancement of peptides to safely
elicit high-titre antibody responses such as the use of albumin-
binding amphiphilic molecular groups may present new
opportunities in the development of cost-effective vaccines.
An affordable and highly effective malaria vaccine would
undoubtedly be an important control measure to improve the
lives of the billions of people who live at risk of this deadly
infectious disease.
Methods
Protein-based methods. Recombinant P. falciparum proteins were expressed by
transient transfection of HEK293 cells from the 3D7 strain using expression
plasmids described in refs 24,25. With the exception of RIPR that was expressed in
Freestyle 293-F cells (ThermoFisher Scientific), all proteins were expressed using
HEK293-6E cells43. RH5 was processed (Fig. 1a) when expressed in HEK293 media
supplemented with fetal calf serum; this processing was reduced by using HEK293
cells adapted to serum-free media and prevented where necessary by the addition
of (2 to 10mgml 1) aprotinin. Briefly, all plasmids were chemically synthesized
using codons optimized for expression in human cells, potential N-linked
glycosylation sequons were mutated, and contained a C-terminal rat Cd4d3þ 4
tag. Where appropriate, monomeric ‘bait’ proteins were enzymatically
monobiotinylated by cotransfection with a plasmid encoding a secreted BirA
enzyme as described23,44. His-tagged proteins were purified from supernatants on
HisTrap HP columns using an ÄKTAexpress or ÄKTApure (GE Healthcare) and
resolved by gel filtration on a Superdex 200 Increase 10/300 column (GE
Healthcare) as described45. Regions encoding defined domains of RH5 or P113
were amplified by PCR from plasmids encoding the entire ectodomain and cloned
into appropriate expression plasmids. Boundaries for each of the recombinant
protein fragments are indicated using amino-acid numbers pertaining to the P.
falciparum 3D7 sequence without signal peptide. Recombinant proteins were
resolved on Bis-Tris 4–12% SDS polyacrylamide gels and stained with colloidal
Coomassie blue. Where necessary, proteins were blotted on to Amersham HyBond
PVDF membranes by transfer in NuPAGE transfer buffer (ThermoFisher
Scientific) for 1 h at 40V; membranes were blocked in PBS/2% BSA for 3 h, probed
with 1:10,000 primary antibodies, washed four times with PBST (PBS/0.1% Tween-
20), and then incubated with 1:5,000 of anti-rabbit horseradish peroxidase-
conjugated secondary (ThermoFisher Scientific Cat. No. G21234). After further
washing four times in PBST blots were exposed on film using West Pico ECL
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Figure 6 | An ‘amph-vaccine’ based on RH5Nt elicits antibodies that inhibit parasite growth in vitro. (a) A synthetic 116 amino-acid peptide
corresponding to RH5Nt interacts with P113. Serial dilutions of purified P113 (Y1-N653) were injected over the RH5Nt peptide immobilized on a streptavidin-
coated sensor chip after the C-terminal cysteine was conjugated to biotin functionalized with maleimide. Reference-subtracted binding data are shown
(black lines) which fit well to a 1:1 binding model (red lines). (b) Structure of an ‘amph-vaccine’ based on RH5Nt created by conjugating the RH5Nt peptide
to maleimide-functionalized 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] (PEG2000-DSPE). Antibodies
raised against RH5Nt peptide (Anti-pRH5Nt) blocked RH5 binding to P113 (c), but not to basigin (d). The indicated concentrations of protein-G purified
rabbit polyclonal antibodies were incubated with RH5 b-lactamase-tagged prey proteins before presenting them to immobilized P113 (c) or basigin (d)
baits. Prey binding was quantified by nitrocefin hydrolysis at 485 nm; polyclonal antibodies to RH5FL and AMA1 were used as positive and negative
controls respectively. (e) Polyclonal antibodies elicited against the RH5Nt amph-vaccine inhibited erythrocyte invasion of both 3D7 and Dd2 strain of
P. falciparum. Data points represent means±95% confidence interval, n¼ 3; a representative experiment from two independent experiments is shown.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14333
8 NATURE COMMUNICATIONS | 8:14333 | DOI: 10.1038/ncomms14333 | www.nature.com/naturecommunications
(ThermoFisher Scientific). Uncropped gels and blots used to produce Figs 1a, 2c
and 4e and Supplementary Fig. 4 are provided in Supplementary Fig. 7.
Recombinant proteins analysed by SEC were resolved by native PAGE using Bis-
Tris polyacrylamide gels at 150V and colloidal Coomassie staining. Edman
N-terminal protein sequencing was performed by the PNAC facility at the
University of Cambridge using standard procedures.
Avidity-based extracellular protein interaction screening. AVEXIS was
performed essentially as described23. Monomeric biotinylated bait proteins and
highly avid pentameric b-lactamase-tagged prey protein activities were prepared
and their expression levels normalized as described44 to B5 mgml 1 before their
use in interaction screening. Briefly, biotinylated baits were immobilized in
streptavidin-coated 96-well microtitre plates, washed with PBST (PBS/0.1%
Tween-20), incubated with prey proteins, washed three times with PBST and
any captured preys quantified by adding the colorimetric b-lactamase substrate
nitrocefin and measuring the absorbance of the hydrolysis products at 485 nm.
The negative control in each screen was the query prey protein probed against the
Cd4d3þ 4 tag alone. Positive control interactions included the human basigin bait
detected with the RH5 prey, and the rat Cd200 bait with rat Cd200R prey.
SPR. SPR was performed using a Biacore T100 instrument (GE Healthcare) as
previously described45. Briefly, B150 RU of biotinylated rat Cd4d3þ 4 was
captured on a streptavidin-coated sensor chip (GE Healthcare) to be used as a
reference, and an equivalent molar quantity of query protein was captured in the
query flow cell. Immediately before SPR experiments, analyte proteins were
separated by size exclusion chromatography to remove aggregates, which even in
very small amounts can affect kinetic measurements46. Although monomeric
RH5Nt resolved as a monodisperse peak by gel filtration at the expected size, the
initial binding kinetics of the RH5Nt-P113 interaction were initially rapid followed
by much slower binding kinetics, and this behaviour was mirrored in the
dissociation phase once the injection of RH5Nt was complete, suggesting the
presence of small amounts of active multimeric material; attempts were made to
reduce this affect by performing SPR immediately after size separation. Kinetic
studies were performed at high flow rates (100 ml min 1) to reduce confounding
rebinding effects and equilibrium binding analysis at 10 ml min 1. Where
necessary, surfaces were regenerated by injecting a pulse of 2M NaCl. The
retention of immobilized ligand surface activity was confirmed by showing
equivalent binding responses of the same concentration before and after chip
regeneration. Binding data were analysed in the Biacore T100 evaluation software
(GE Healthcare) using reference-subtracted sensorgrams. Independent protein
preparations of both analyte and ligand proteins were used for replicate
experiments, all of which were performed at 37 C.
RH5Nt amph-vaccine and antibodies. A 117 amino-acid peptide corresponding
to RH5Nt (F1-K116) with an additional C-terminal cysteine was chemically
synthesized (LifeTein). The peptide was dissolved in DMF and conjugated to
maleimide-PEG2000-DSPE (Avanti Polar Lipids) at a 1:2 molar ratio overnight
at room temperature with rotation. Polyclonal antisera were raised by immunizing
rabbits six times with 100mg of purified antigen in Freund’s adjuvant in rabbits
(Cambridge Research Biochemicals) in strict accordance with UK Home Office
governmental regulations and the local Sanger Institute animal welfare ethical
review board. Polyclonal antisera were similarly raised against full-length CyRPA
and the P113 Y1-N653 fragment expressed in mammalian cells as rat Cd4d3þ 4-
6His tagged proteins and purified using Ni2þ -NTA chromatography. The sera
were purified according to manufacturer’s instructions on an ÄKTA system using
separate Hi-Trap Protein G HP columns (GE Healthcare) for each rabbit serum.
The fractions were eluted with 0.2M glycine (pH 2.7) directly into a neutralization
buffer (1M Tris:Cl pH 9.0) and immediately dialysed into PBS.
P. falciparum culture and invasion assays. The 3D7 and Dd2 P. falciparum
strains were obtained from BEI Resources and cultured in human Oþ
erythrocytes at 5% haematocrit in complete medium (RPMI-1640 containing 10%
Albumax under an atmosphere of 1% O2, 3% CO2 and 96% N2. Blood was
purchased from UK NHS Blood and Transplant (NHSBT) services. Consent from
healthy volunteers was obtained by NHSBT using a study protocol approved by the
National Research Ethics Service Committee East of England—Cambridge South
and by the Sanger Institute Human Materials and Data Management Committee;
samples were provided fully anonymized. Invasion assays were carried out in
round-bottom 96 well plates, with a culture volume of 100 ml per well at a
haematocrit of 2%. Parasites were synchronized at early stages with 5% (w/v)
D-sorbitol; trophozoite stage parasites were mixed with blocking agent and then
incubated in the plates for 24 h at 37 C inside a static incubator culture chamber.
At the end of the incubation period erythrocytes were collected and parasitized
erythrocytes were stained with 2 mM Hoechst 33342. Purified antibodies were
dialysed into RPMI (GIBCO) before use. Hoechst 33342 stained samples
were excited with a 355 nm UV laser (20mW) on a BD LSRH flow cytometer
Rhoptry Microneme
AMA1/RON
complex
1 2 3
Basigin
P113
RH5FL
RH5Ct/
CyRPA/
RIPR complex
Figure 7 | A model describing the role of the RH5 complex and its interaction with P113 during erythrocyte invasion. Before invasion, the different
components of the RH5 invasion complex are segregated within different subcellular locations of the merozoite and therefore purposefully prevented from
interacting: RH5 is located in the rhoptries, CyRPA and RIPR in the micronemes, and P113 on the surface of the merozoite. Following engagement of the
erythrocyte and release of the rhoptry contents, RH5 is tethered via its N-terminal region at the merozoite membrane by the surface-localized multimeric
P113, enabling direct presentation to the basigin receptor on the erythrocyte surface and leading to the formation of an open connection for other invasion
ligands to be secreted (1). The AMA1/RON complex initiates the formation of the moving junction (2). The localized secretion of CyRPA and RIPR from the
micronemes leads to the formation of the RH5-CyRPA-RIPR-basigin invasion complex which, either because of the cleavage of RH5 to remove the
N-terminal region, and/or because P113 and RIPR cannot simultaneously bind the RH5 complex would release RH5 from the P113 tether at the merozoite
surface to licence invasion (3). The P113-RH5 complex would therefore only be fleetingly formed during the rapid invasion process resulting in a soluble
post-invasion RH5Ct-CyRPA-RIPR complex.
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(BD Biosciences) and detected with a 450/50 filter. BD FACS Diva was used to
collect 100,000 events for each sample. FSC and SSC voltages of 423 and 198,
respectively, and a threshold of 2,000 on FSC were applied to gate the erythrocyte
population. The data collected were further analysed with FlowJo (Tree Star).
All experiments were carried out in triplicate.
Immunofluorescence of P. falciparum. Air-dried thin films of late-stage schizonts
and free merozoites were fixed in ice-cold methanol. Fixed parasites were
permeabilized in PBS/Triton X100 1% (except in Supplementary Fig. 1b) and
blocked in PBS/3%BSA/10%goat serum. Parasites were stained with the primary
antibodies: 1:10,000 rabbit anti-P113 polyclonal (this study), 1:400 mouse anti-
MSP9 polyclonal (a gift of Alexander Douglas11), 1:5,000 mouse anti-MSP1
monoclonal (a gift of Michael Blackman), 1:1,000 rat anti-MTIP47 overnight at
4 C. After three washes, the parasites were incubated with secondary antibodies
(goat anti-rabbit IgG (Hþ L) AlexaFluor 488, anti-mouse IgG (Hþ L) AlexaFluor
555, goat anti-rat IgG (Hþ L) AlexaFluor 555, all ThermoFisher Scientific
Cat. No.s A-11008, A-21424 and A-21434, respectively) diluted 1:500 for 1 h at
room temperature. The samples were washed in PBS three times and mounted in
Prolong Gold (Molecular Probes) with DAPI before images were captured on a
Leica DMi8 fluorescent microscope and processed using Leica LAS X software and
Photoshop.
P113 purification from parasite cultures. P. falciparum parasites were tightly
synchronized by alternating treatment between 5% D-sorbitol and isolation on a
Percoll gradient. Erythrocytes containing mature schizonts from 50ml cultures
(2.5% haematocrit and 2 to 7% parasitaemia) were isolated on a Percoll gradient
and lysed with 0.15% saponin. The parasite pellet was washed with PBS and
resuspended in lysis buffer (25mM Tris-Cl, pH 7.4, 1mM EDTA, 1% NP40,
150mM NaCl, 5% glycerol, 5mM AEBSF, 4mM aprotinin, 0.2mM bestatin, 75 mM
E64, 0.1mM Leupeptin, 50mM Pepstatin A). The release of P113 into the aqueous
phase was improved by either the addition of 1% Triton X-100 or vortexing and
rotation at room temperature for 1 to 4 h. The lysate supernatant was incubated
with streptavidin-conjugated agarose beads for 1 h at room temperature to
remove non-specific binders. Streptavidin agarose beads (Pierce) were loaded with
monomeric biotinylated RH5Ct or RH5Nt (as per manufacturer’s instructions) and
added to the lysate supernatant (B109 parasites per 100 mg of RH5Ct or RH5Nt
protein). After incubating for 4 h at room temperature the agarose beads were
washed three times (PBS, 0.1% Tween 20) and the bound proteins eluted in 2%
LDS. The eluate was analysed by SDS–PAGE under reducing conditions and
probed with P113 polyclonal antibodies.
Cell surface expression of P113. Plasmids containing the CyRPA and P113
coding sequences were chemically synthesized as described above for the merozoite
cell surface library but with three differences: constructs included their endogenous
signal peptides, the GPI-sequence of P113 was retained, and the proteins lacked
any protein tags; these plasmids were transiently transfected in HEK293 cells. After
24 and 48 h the culture supernatant and cells were collected, probed with the
appropriate polyclonal IgG raised against CyRPA or P113 and stained with
anti-rabbit IgG (Hþ L) conjugated to Alexa Fluor 568 (ThermoFisher Scientific
Cat. No. A10042). PBS was used to wash the cells between antibody incubations.
Flow cytometry was performed on a BD LSR Fortessa.
Data availability. All relevant data are available from the authors upon request.
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